CENTRAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Centrax, and when can generic versions of Centrax launch?
Centrax is a drug marketed by Parke Davis and is included in two NDAs.
The generic ingredient in CENTRAX is prazepam. There are four drug master file entries for this compound. Additional details are available on the prazepam profile page.
Summary for CENTRAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Patent Applications: | 4,051 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CENTRAX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CENTRAX
US Patents and Regulatory Information for CENTRAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | CENTRAX | prazepam | CAPSULE;ORAL | 018144-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | CENTRAX | prazepam | TABLET;ORAL | 017415-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | CENTRAX | prazepam | CAPSULE;ORAL | 018144-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | CENTRAX | prazepam | CAPSULE;ORAL | 018144-003 | May 10, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |